Finally, we reported that full-length HAPLN1 is processed into the HAPLN1 matrikine by matrix metalloproteinase 2, also produced by MM patient–derived BMSCs (Mark et al, 2022). This evidence concerns the gene MMP2 and Miyoshi myopathy.